ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01416181
Brief Title: A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis (ASCEND in SPMS)

First Submitted : July 21, 2011
First Submitted that Met QC Criteria : August 11, 2011
First Posted : August 12, 2011 (Estimate)

Results First Submitted : April 13, 2017
Results First Submitted that Met QC Criteria : May 24, 2017
Results First Posted : June 27, 2017

Certification/Extension First Submitted : July 15, 2016
Certification/Extension First Submitted that Met QC Criteria : July 15, 2016
Certification/Extension First Posted : July 19, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 10, 2017
Last Update Posted : September 11, 2017